BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37025058)

  • 1. Opt-in for secondary findings as part of diagnostic whole-exome sequencing: Real-life experience from an international diagnostic laboratory.
    Brunfeldt M; Kaare M; Saarinen I; Koskenvuo J; Kääriäinen H
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2180. PubMed ID: 37025058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
    Smith LA; Douglas J; Braxton AA; Kramer K
    J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation among Consent Forms for Clinical Whole Exome Sequencing.
    Fowler SA; Saunders CJ; Hoffman MA
    J Genet Couns; 2018 Feb; 27(1):104-114. PubMed ID: 28689263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
    Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
    Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of medical management and genetic counseling options pre- and post-whole exome sequencing for patients with positive and negative results.
    Matias M; Wusik K; Neilson D; Zhang X; Valencia CA; Collins K
    J Genet Couns; 2019 Apr; 28(2):182-193. PubMed ID: 30648779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
    Shahmirzadi L; Chao EC; Palmaer E; Parra MC; Tang S; Gonzalez KD
    Genet Med; 2014 May; 16(5):395-9. PubMed ID: 24113345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary findings in 421 whole exome-sequenced Chinese children.
    Chen W; Li W; Ma Y; Zhang Y; Han B; Liu X; Zhao K; Zhang M; Mi J; Fu Y; Zhou Z
    Hum Genomics; 2018 Sep; 12(1):42. PubMed ID: 30217213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.
    Kasak L; Lillepea K; Nagirnaja L; Aston KI; Schlegel PN; Gonçalves J; Carvalho F; Moreno-Mendoza D; Almstrup K; Eisenberg ML; Jarvi KA; O'Bryan MK; Lopes AM; Conrad DF; ; Punab M; Laan M
    Hum Reprod; 2022 Jun; 37(7):1652-1663. PubMed ID: 35535697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
    Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
    Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Whole Exome Sequencing: an Assessment of Parents' Perceived and Actual Understanding.
    Tolusso LK; Collins K; Zhang X; Holle JR; Valencia CA; Myers MF
    J Genet Couns; 2017 Aug; 26(4):792-805. PubMed ID: 27987066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number alterations involving 59 ACMG-recommended secondary findings genes.
    Yatsenko SA; Aarabi M; Hu J; Surti U; Ortiz D; Madan-Khetarpal S; Saller DN; Bellissimo D; Rajkovic A
    Clin Genet; 2020 Dec; 98(6):577-588. PubMed ID: 33009833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term impact of receiving incidental findings on parents undergoing genome-wide sequencing.
    Cheung F; Birch P; Friedman JM; ; ; Elliott AM; Adam S
    J Genet Couns; 2022 Aug; 31(4):887-900. PubMed ID: 35128755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation.
    Headrick AT; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Penny DJ; Kim JJ; Landstrom AP
    Mol Genet Genomic Med; 2019 Jun; 7(6):e593. PubMed ID: 30985088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
    [No Abstract]   [Full Text] [Related]  

  • 18. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise.
    Landstrom AP; Fernandez E; Rosenfeld JA; Yang Y; Dailey-Schwartz AL; Miyake CY; Allen HD; Penny DJ; Kim JJ
    Heart Rhythm; 2018 Jul; 15(7):1042-1050. PubMed ID: 29501670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [UTILIZATION OF WHOLE EXOME SEQUENCING IN DIAGNOSTICS OF GENETIC DISEASE: RABIN MEDICAL CENTER'S EXPERIENCE].
    Cohen L; Orenstein N; Weisz-Hubshman M; Bazak L; Davidov B; Reinstein E; Tzur S; Behar D; Smirin-Yosef P; Salmon-Divon M; Gross A; Shohat M; Basel-Vanagaite L
    Harefuah; 2017 Apr; 156(4):212-216. PubMed ID: 28551919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.